1. Home
  2. AVIR vs MBCN Comparison

AVIR vs MBCN Comparison

Compare AVIR & MBCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVIR
  • MBCN
  • Stock Information
  • Founded
  • AVIR 2012
  • MBCN 1901
  • Country
  • AVIR United States
  • MBCN United States
  • Employees
  • AVIR N/A
  • MBCN N/A
  • Industry
  • AVIR Medicinal Chemicals and Botanical Products
  • MBCN Major Banks
  • Sector
  • AVIR Health Care
  • MBCN Finance
  • Exchange
  • AVIR Nasdaq
  • MBCN Nasdaq
  • Market Cap
  • AVIR 251.7M
  • MBCN 225.0M
  • IPO Year
  • AVIR 2020
  • MBCN N/A
  • Fundamental
  • Price
  • AVIR $3.09
  • MBCN $24.57
  • Analyst Decision
  • AVIR Hold
  • MBCN Hold
  • Analyst Count
  • AVIR 1
  • MBCN 1
  • Target Price
  • AVIR $6.88
  • MBCN $32.00
  • AVG Volume (30 Days)
  • AVIR 318.0K
  • MBCN 8.7K
  • Earning Date
  • AVIR 03-03-2025
  • MBCN 01-23-2025
  • Dividend Yield
  • AVIR N/A
  • MBCN 3.36%
  • EPS Growth
  • AVIR N/A
  • MBCN N/A
  • EPS
  • AVIR N/A
  • MBCN 1.92
  • Revenue
  • AVIR N/A
  • MBCN $65,885,000.00
  • Revenue This Year
  • AVIR N/A
  • MBCN N/A
  • Revenue Next Year
  • AVIR N/A
  • MBCN $6.00
  • P/E Ratio
  • AVIR N/A
  • MBCN $13.02
  • Revenue Growth
  • AVIR N/A
  • MBCN N/A
  • 52 Week Low
  • AVIR $2.75
  • MBCN $20.61
  • 52 Week High
  • AVIR $4.60
  • MBCN $34.00
  • Technical
  • Relative Strength Index (RSI)
  • AVIR 48.26
  • MBCN 40.77
  • Support Level
  • AVIR $3.04
  • MBCN $24.56
  • Resistance Level
  • AVIR $3.25
  • MBCN $26.42
  • Average True Range (ATR)
  • AVIR 0.13
  • MBCN 0.90
  • MACD
  • AVIR 0.01
  • MBCN -0.02
  • Stochastic Oscillator
  • AVIR 54.29
  • MBCN 0.38

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

About MBCN Middlefield Banc Corp.

Middlefield Banc Corp is a United States-based bank holding company. It offers customers, banking services including checking, savings, negotiable order of withdrawal (NOW) accounts, money market accounts, time deposits, commercial loans, real estate loans, a variety of consumer loans, safe deposit facilities, and travelers' checks. It also provides online banking and bill payment services to individuals and online cash management services to business customers.

Share on Social Networks: